IPRAGLIFLOZIN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C21H21FO5S
Molecular Weight	404.452
Optical Activity	UNSPECIFIED
Defined Stereocenters	5 / 5
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of IPRAGLIFLOZIN

Structure Search

SMILES

OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C2=CC=C(F)C(CC3=CC4=C(S3)C=CC=C4)=C2

InChI

InChIKey=AHFWIQIYAXSLBA-RQXATKFSSA-N

InChI=1S/C21H21FO5S/c22-15-6-5-12(21-20(26)19(25)18(24)16(10-23)27-21)7-13(15)9-14-8-11-3-1-2-4-17(11)28-14/h1-8,16,18-21,23-26H,9-10H2/t16-,18-,19+,20-,21+/m1/s1

HIDE SMILES / InChI

Molecular Formula	C21H21FO5S
Molecular Weight	404.452
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	5 / 5
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 17:56:56 UTC 2023` Edited by `admin` on `Sat Dec 16 17:56:56 UTC 2023`
Record UNII	3N2N8OOR7X
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

IPRAGLIFLOZIN

Official Name

English

D-GLUCITOL, 1,5-ANHYDRO-1-C-(3-(BENZO(B)THIEN-2-YLMETHYL)-4-FLUOROPHENYL)-, (1S)-

Common Name

English

ASP-1941

Code

English

ipragliflozin [INN]

Common Name

English

(1S)-1,5-ANHYDRO-1-C-(3-((1-BENZOTHIOPHEN-2-YL)METHYL)-4-FLUOROPHENYL)-D-GLUCITOL

Common Name

English

IPRAGLIFLOZIN [MI]

Common Name

English

Ipragliflozin [WHO-DD]

Common Name

English

Classification Tree Code System Code

WHO-ATC

A10BK05

Created by admin on Sat Dec 16 17:56:57 UTC 2023 , Edited by admin on Sat Dec 16 17:56:57 UTC 2023

Code System Code Type Description

CAS

761423-87-4

Created by admin on Sat Dec 16 17:56:57 UTC 2023 , Edited by admin on Sat Dec 16 17:56:57 UTC 2023

PRIMARY

MESH

C572941

Created by admin on Sat Dec 16 17:56:57 UTC 2023 , Edited by admin on Sat Dec 16 17:56:57 UTC 2023

PRIMARY

PUBCHEM

10453870

Created by admin on Sat Dec 16 17:56:57 UTC 2023 , Edited by admin on Sat Dec 16 17:56:57 UTC 2023

PRIMARY

DRUG BANK

DB11698

Created by admin on Sat Dec 16 17:56:57 UTC 2023 , Edited by admin on Sat Dec 16 17:56:57 UTC 2023

PRIMARY

NCI_THESAURUS

C166685

Created by admin on Sat Dec 16 17:56:57 UTC 2023 , Edited by admin on Sat Dec 16 17:56:57 UTC 2023

PRIMARY

EPA CompTox

DTXSID701032738

Created by admin on Sat Dec 16 17:56:57 UTC 2023 , Edited by admin on Sat Dec 16 17:56:57 UTC 2023

PRIMARY

SMS_ID

100000128632

Created by admin on Sat Dec 16 17:56:57 UTC 2023 , Edited by admin on Sat Dec 16 17:56:57 UTC 2023

PRIMARY

WIKIPEDIA

Ipragliflozin

Created by admin on Sat Dec 16 17:56:57 UTC 2023 , Edited by admin on Sat Dec 16 17:56:57 UTC 2023

PRIMARY

DRUG CENTRAL

4890

Created by admin on Sat Dec 16 17:56:57 UTC 2023 , Edited by admin on Sat Dec 16 17:56:57 UTC 2023

PRIMARY

EVMPD

SUB35918

Created by admin on Sat Dec 16 17:56:57 UTC 2023 , Edited by admin on Sat Dec 16 17:56:57 UTC 2023

PRIMARY

FDA UNII

3N2N8OOR7X

Created by admin on Sat Dec 16 17:56:57 UTC 2023 , Edited by admin on Sat Dec 16 17:56:57 UTC 2023

PRIMARY

INN

9258

Created by admin on Sat Dec 16 17:56:57 UTC 2023 , Edited by admin on Sat Dec 16 17:56:57 UTC 2023

PRIMARY

MERCK INDEX

m11865

Created by admin on Sat Dec 16 17:56:57 UTC 2023 , Edited by admin on Sat Dec 16 17:56:57 UTC 2023

PRIMARY

Related Record Type Details


					ZHQ2R96QPT

SODIUM/GLUCOSE COTRANSPORTER 2

TARGET -> INHIBITOR


					M6N3GK48A4

IPRAGLIFLOZIN L-PROLINE

SALT/SOLVATE -> PARENT

Related Record Type Details


					3N2N8OOR7X

ACTIVE MOIETY